Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gender differences in pharmacokinetics

C H Gleiter1, U Gundert-Remy

  • 1Department of Clinical Pharmacology, University of Göttingen, Germany.

European Journal of Drug Metabolism and Pharmacokinetics
|April 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A tool to assess the internal validity of toxicokinetic studies.

Archives of toxicology·2026
Same author

Fluoride intake during pregnancy: calculation of realistic exposure scenarios for individual risk assessment.

Archives of toxicology·2025
Same author

New aspects in deriving health-based guidance values for bromate in swimming pool water.

Archives of toxicology·2022
Same author

The EU chemicals strategy for sustainability: critical reflections on proposed regulatory changes for endocrine disruptors and mixture toxicity.

Archives of toxicology·2022
Same author

Use of mechanistic information to derive chemical-specific adjustment factors - Refinement of risk assessment.

Regulatory toxicology and pharmacology : RTP·2020
Same author

Critical evaluation of human health risks due to hydraulic fracturing in natural gas and petroleum production.

Archives of toxicology·2020
Same journal

Population Pharmacokinetic Modeling Study of Glibenclamide in Chinese Healthy Volunteers.

European journal of drug metabolism and pharmacokinetics·2026
Same journal

A Relative Bioavailability Study of Vepdegestrant Tablets in Healthy Adult Participants.

European journal of drug metabolism and pharmacokinetics·2026
Same journal

Population Pharmacokinetics of Amikacin in Non-Neonatal Pediatric Patients: A Scoping Review.

European journal of drug metabolism and pharmacokinetics·2026
Same journal

Investigating the Impact of Calcium Channel Blockers on the Pharmacokinetics of Lapatinib: Possible Role of Cytochrome P450 Enzymes and P-glycoprotein Efflux Transporters.

European journal of drug metabolism and pharmacokinetics·2026
Same journal

Clinical Relevance of the 516 G>T Polymorphism in CYP2B6 and Its Effects on Efavirenz Concentrations in Patients with HIV and Tuberculosis: A Meta-analysis.

European journal of drug metabolism and pharmacokinetics·2026
Same journal

Toxicity-Tailored Thresholds of Delayed Methotrexate Elimination in Non-Hodgkin Lymphoma: A Population-Based Approach to Therapy Optimization.

European journal of drug metabolism and pharmacokinetics·2026
See all related articles

Women

Area of Science:

  • Pharmacology and Drug Metabolism
  • Clinical Trial Diversity

Background:

  • Underrepresentation of women in clinical trials, especially Phase I studies, can lead to suboptimal drug management.
  • Existing data suggest significant gender-based pharmacokinetic differences, necessitating further investigation.
  • Hormonal fluctuations throughout a woman's life can impact drug efficacy and safety.

Purpose of the Study:

  • To highlight the implications of gender disparities in clinical trials.
  • To review existing evidence on sex-based pharmacokinetic differences.
  • To underscore the need for systematic research into hormonal influences on drug metabolism.

Main Methods:

  • Review of existing literature and case examples on gender-based pharmacokinetics.
  • Analysis of data on drug elimination and metabolic enzyme activity (e.g., CYP 3A4).

Related Experiment Videos

  • Examination of the effects of hormonal factors (oral contraceptives, pregnancy, HRT) on drug metabolism.

    • Main Results:

    • CYP 3A4 activity is higher in women than men, while other CYP isoenzymes and glucuronidation are more active in men.
    • Oral contraceptives can alter drug metabolism.
    • Increased elimination of antiepileptics during pregnancy can lead to seizures without dose adjustments.
    • Hormonal replacement therapy (HRT) impacts the pharmacokinetics of co-administered drugs.

    Conclusions:

    • Gender-specific pharmacokinetic data are crucial for safe and effective drug therapy.
    • Systematic research is required to fully understand the impact of hormonal changes on drug metabolism in women.
    • Further investigation into HRT's pharmacokinetic interactions is essential due to its increasing use.